{
    "title": "Corporate America weighs business impact of new weight-loss drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12677091/Corporate-America-weighs-business-impact-new-weight-loss-drugs.html",
    "date": "2023-10-26",
    "keywords": [
        "weightloss",
        "impact",
        "use",
        "popularity",
        "food",
        "ozempic",
        "year",
        "ceo",
        "term",
        "beverage",
        "class",
        "consumption",
        "health",
        "officer",
        "company",
        "robert",
        "dialysis",
        "kidney",
        "drug",
        "demand",
        "market",
        "insulin",
        "investor",
        "risk",
        "glp1",
        "wegovy",
        "lillys",
        "blood",
        "sugar",
        "weight",
        "portion",
        "change",
        "wellness",
        "half",
        "hugh",
        "johnston",
        "chocolate",
        "business",
        "keurig",
        "dr",
        "gamgort",
        "coffee",
        "care",
        "effect",
        "future",
        "davita",
        "disease",
        "device",
        "slowdown",
        "jampj",
        "joseph",
        "wolk",
        "hip",
        "knee",
        "monitoring",
        "ford",
        "insulet",
        "corp",
        "mounjaro",
        "time",
        "maker",
        "surgical",
        "growth",
        "rate",
        "surgery",
        "boston",
        "loss",
        "heart",
        "minor",
        "mckesson",
        "boost",
        "bhanvi",
        "satija",
        "mariam",
        "rajesh",
        "bengaluru",
        "editing",
        "mrigank",
        "dhaniwala"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}